Mark Hill
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes, Colorectal and Anal Carcinomas, Cancer Treatment and Pharmacology, Esophageal Cancer Research and Treatment
Most-Cited Works
- → Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer(2011)779 cited
- → Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging–Defined Poor-Risk Rectal Cancer(2006)479 cited
- → Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial(2013)392 cited
- → Skin Color and the Perception of Attractiveness among African Americans: Does Gender Make a Difference?(2002)368 cited
- → Phase III Trial of Capecitabine Plus Oxaliplatin As Adjuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 Patients(2006)298 cited
- → Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial(2015)297 cited
- → Childhood conditions that predict survival to advanced ages among African–Americans(1998)293 cited
- → Baseline quality of life predicts survival in patients with advanced colorectal cancer(2002)247 cited
- → Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial(2020)235 cited
- → African-american mortality at older ages: Results of a matching study(1996)191 cited